ALPS Medical Breakthroughs ETF (SBIO) — ()
Key Metrics
News
Small-Cap Biotech Stocks Ready to Shine
Published: by:
Sentiment: Positive ()
Biotech stocks and related ETFs are in the midst of a lengthy period of underperformance. For the three years ending July 9, the largest ETF in the category returned just …
Read More
Healthcare Innovation Alive & Well in SBIO
Published: by:
Sentiment: Positive ()
It's understandable investors are frustrated with broader measures of small-cap equities. They've been hearing about the possibility of smaller stocks outperforming larger counterparts for a while.
Read More
This Tech Sector ETF Could Zig Where Others Zag
Published: by:
Sentiment: Neutral ()
With tech earnings arriving, many investors are still likely fearing a downturn for key information technology stocks. The so-called Magnificent Seven stocks delivered significant performance for investors last year.
Read More
About ALPS Medical Breakthroughs ETF SBIO
The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.